This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Live coverage has ended. The full story is below.
This article will be updated throughout the day, so check back often for more daily updates.
The markets are in wait and see mode. The U.S. destroyed Iranian nuclear sites, raising the likelihood that the Middle Eastern nation is set to target key energy assets or move to close the Strait of Hormuz. The price of Brent oil soared to almost $80 per barrel, a level it hasn’t seen in months amid the escalating Middle East conflict. The U.S. dollar is increasing against other currencies on Monday.
Big Tech stocks are mostly lower with the exception of Tesla (Nasdaq: TSLA | TSLA Price Prediction), which is gaining 4.7% amid the beta rollout of robo-taxis in Texas. Meanwhile, Bank of America predicts that the price of gold could soar as high as $4,000 per ounce in the coming year, owing to the debt crisis and geopolitical uncertainty.
Another IPO is making its stock market debut today. Cement maker Amrize (NYSE: AMRZ), the U.S. division of Swiss parent Holcim, began trading on the NYSE. The stock’s market capitalization rose to $28.3 billion in early morning trading. Separately, home sales data is due out later this morning.
Here’s a look at the performance as of morning trading:
Dow Jones Industrial Average: Up 24.97 (+0.06%)
Nasdaq Composite: Up 4.03 (+0.01%)
S&P 500: Up 11.31 (+0.21%)
Market Movers
Novo Nordisk (NYSE: NVO) has reportedly shuttered collaboration with Hims & Hers Health (NYSE: HIMS). As a result, direct access to the popular weight-loss drug Wegovy will no longer be available through Hims & Hers Health, per Reuters. HIMS stock is plummeting by 27.4%.
DoorDash (Nasdaq: DASH) is gaining 3.5% after Wall Street firm Raymond James upgraded the stock to a “strong buy” with a bullish $260 price target attached.
Contact [email protected] for any questions or corrections.